ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 264,28
0,13%
Dow Jones
44 296,51
0,97%
DAX
19 378,76
0,38%
Brent Oil
74,395
-0,50%
Bitcoin
98 405,24
0,37%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. NanoVibronix Inc (NAOV)

  7. NanoVibronix Inc (NAOV) Actualités

NAOV

NanoVibronix (NAOV)

NanoVibronix Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:NAOV
DateHeureSourceTitreSymboleSociété
22/11/202422h18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NAOVNanoVibronix Inc
14/11/202423h17Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:NAOVNanoVibronix Inc
14/11/202421h12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NAOVNanoVibronix Inc
12/11/202414h00Business WireNanoVibronix Provides Business UpdateNASDAQ:NAOVNanoVibronix Inc
29/10/202421h29Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:NAOVNanoVibronix Inc
29/10/202421h26Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:NAOVNanoVibronix Inc
29/10/202421h18Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:NAOVNanoVibronix Inc
09/10/202414h30Business WireNanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in GermanyNASDAQ:NAOVNanoVibronix Inc
23/09/202414h30Business WireNanoVibronix Signs Letter of Intent with Potential New DistributorNASDAQ:NAOVNanoVibronix Inc
21/08/202414h30Business WireNanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to StockholdersNASDAQ:NAOVNanoVibronix Inc
22/05/202414h30Business WireNanoVibronix Announces Commencement of UroShield Clinical Study at the University of MichiganNASDAQ:NAOVNanoVibronix Inc
16/05/202414h30Business WireNanoVibronix Issues Letter to StockholdersNASDAQ:NAOVNanoVibronix Inc
14/05/202414h30Business WireNanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShieldNASDAQ:NAOVNanoVibronix Inc
01/05/202414h00Business WireNanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs’ FSS Contract AwardNASDAQ:NAOVNanoVibronix Inc
28/03/202413h30Business WireNanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShieldNASDAQ:NAOVNanoVibronix Inc
26/02/202423h32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NAOVNanoVibronix Inc
14/02/202421h45Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:NAOVNanoVibronix Inc
06/12/202315h00Business WireNanoVibronix Featured in Your Bladder Health MagazineNASDAQ:NAOVNanoVibronix Inc
04/12/202315h00Business WireNanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution OpportunityNASDAQ:NAOVNanoVibronix Inc
28/11/202315h00Business WireNanoVibronix Announces Agreement for Clinical Study of UroShield at the University of MichiganNASDAQ:NAOVNanoVibronix Inc
21/11/202314h30Business WireNanoVibronix Regains Nasdaq ComplianceNASDAQ:NAOVNanoVibronix Inc
14/11/202314h30Business WireNanoVibronix Issues Letter to ShareholdersNASDAQ:NAOVNanoVibronix Inc
07/11/202314h30Business WireNanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1NASDAQ:NAOVNanoVibronix Inc
27/09/202314h00Business WireNanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services’ Drug TariffNASDAQ:NAOVNanoVibronix Inc
22/09/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:NAOVNanoVibronix Inc
21/09/202316h27Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:NAOVNanoVibronix Inc
21/09/202316h25Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:NAOVNanoVibronix Inc
13/09/202322h45Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:NAOVNanoVibronix Inc
12/09/202322h15Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:NAOVNanoVibronix Inc
06/09/202314h30Business WireNanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual MeetingNASDAQ:NAOVNanoVibronix Inc
 Showing the most relevant articles for your search:NASDAQ:NAOV

Dernières Valeurs Consultées

EU
SGO
Cie de SaintGobain
EU
BEL20
Bel 20
NASDAQ
MSFT
Microsoft
NASDAQ
AAPL
Apple
EU
LR
Legrand
EU
EN
Bouygues
NYSE
MRK
Merck
COIN
SOLUSD
Solana
COIN
AVAXUSD
Avalanche
COIN
DOGEUSD
Dogecoin
NYSE
JPM
JP Morgan Chase
EU
BN
Danone
EU
BNP
BNP Paribas
EU
RI
Pernod Ricard
EU
MC
Lvmh Moet Hennessy Louis...
EU
RNO
Renault
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés

BLACK FRIDAY

ADVFN

Célébrons nos 25 ans Est 1999-2024

Jusqu'à 65% de réduction sur Intégral

Cours Euronext Niveau 1 et carnet d'ordres

Cours Euronext en temps réel et illimités sur le site. Carnet d'ordres Euronext en direct